Recombinant tissue plasminogen activator therapy for pacemaker-induced thrombosis

Basit Öğe Kaydı
dc.contributor.authorIlkay, E.
dc.contributor.authorKaraca, I.
dc.contributor.authorSerhatlioglu, S.
dc.contributor.authorAslan, N.
dc.contributor.authorCihangiroglu, M.
dc.date.accessioned2026-08-12T16:10:30Z
dc.date.issued1998
dc.departmentFırat Üniversitesi
dc.description.abstractA 50-year-old male who developed subclavian vein thrombosis following insertion of a demand pacemaker was treated with a short period of high-dose recombinant tissue plasminogen activator (100 mg over 3 hours). Total thrombolysis was achieved without complications.
dc.identifier.doi10.1177/021849239800600211
dc.identifier.endpage126
dc.identifier.issn0218-4923
dc.identifier.issue2
dc.identifier.scopus2-s2.0-0031873556
dc.identifier.scopusqualityQ3
dc.identifier.startpage125
dc.identifier.urihttps://doi.org/10.1177/021849239800600211
dc.identifier.urihttps://hdl.handle.net/11508/41966
dc.identifier.volume6
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSAGE Publications Inc.
dc.relation.ispartofAsian Cardiovascular and Thoracic Annals
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20260511
dc.subjectalteplase; adult; article; artificial heart pacemaker; case report; Doppler echography; drug megadose; fibrinolytic therapy; human; male; subclavian vein; vein thrombosis
dc.titleRecombinant tissue plasminogen activator therapy for pacemaker-induced thrombosis
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu